Montelukast for Parkinson's disease
Treatments studied
Part of Brain & nervous system clinical trials.
This study tests if montelukast, an asthma medicine, can help people with Parkinson's disease. It is for adults who are already taking levodopa and want to see if adding this drug improves their symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- 18 years or older
- Diagnosed with Parkinson's disease
- Currently taking levodopa for Parkinson's
- Willing to use effective birth control if female and able to become pregnant
- No other cause of Parkinson-like symptoms, such as a stroke or medication side effects
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if metformin, a diabetes drug, can help people with Parkinson's disease. It may improve symptoms or slow progression.
This trial tests if adding celecoxib, an anti-inflammatory drug, to standard Parkinson's treatment can help improve symptoms. If you have Parkinson's disease and are at least 18, this study might be an option for you.
This study tests if etoricoxib, an anti-inflammatory drug, can help people with Parkinson's disease. You may join if you have a confirmed diagnosis and are not using other anti-inflammatory drugs.
This trial tests if a low dose of carbon monoxide (HBI-002) is safe and helpful for people with Parkinson's disease. It requires specific health criteria and stable Parkinson's medication.
This trial tests if adding melatonin can reduce oxidative stress (a kind of cell damage) in people with mild to moderate Parkinson's disease who are already taking levodopa. It aims to see if melatonin helps protect the brain and improve symptoms.
This study tests a new nasal spray called XJN010 for people with Parkinson's who have 'off' episodes—times when their regular medication wears off and symptoms come back. The goal is to see if the spray can safely and effectively help during those periods.
Hear when a new Parkinson Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.